-
Start Preamble
AGENCY:
Food and Drug Administration, Department of Health and Human Services (HHS).
ACTION:
Final rule; technical amendment.
SUMMARY:
The Food and Drug Administration (FDA) is amending its regulations to reflect a change in the name of Division of Dockets Management to Dockets Management Staff and information regarding copies. This action is editorial in nature and is intended to improve the accuracy of the Agency's regulations.
DATES:
This rule is effective July 14, 2023.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Karen Malvin, Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240–402–7500.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
FDA is amending 21 CFR chapter I to update Dockets Management Staff's name change and information regarding copies.
Publication of this document constitutes final action on the changes under the Administrative Procedure Act (5 U.S.C. 553). FDA has determined that notice and public comment are unnecessary because this amendment to the regulations provides only a technical change to update the organizational information for Dockets Management Staff.
Start List of SubjectsList of Subjects
21 CFR Part 3
- Administrative practice and procedure
- Biologics
- Drugs
- Medical devices
21 CFR Part 5
- Authority delegations (Government agencies)
- Imports
- Organization and functions (Government agencies)
21 CFR Part 7
- Administrative practice and procedure
- Consumer protection
- Reporting and recordkeeping requirements
21 CFR Part 10
- Administrative practice and procedure
- News media
21 CFR Parts 12, 13, and 15
- Administrative practice and procedure
21 CFR Part 14
- Administrative practice and procedure
- Advisory committees
- Color additives
- Drugs
- Radiation protection
21 CFR Part 17
- Administrative practice and procedure
- Penalties
21 CFR Part 20
- Confidential business information
- Courts
- Freedom of information
- Government employees
21 CFR Part 25
- Environmental impact statements
- Foreign relations
- Reporting and recordkeeping requirements
21 CFR Part 60
- Administrative practice and procedure
- Drugs
- Food additives
- Inventions and patents
- Medical devices
- Reporting and recordkeeping requirements
21 CFR Part 100
- Administrative practice and procedure
- Food labeling
- Food packaging
- Foods
- Intergovernmental relations
21 CFR Part 101
- Food labeling
- Nutrition
- Reporting and recordkeeping requirements
21 CFR Part 109
- Food packaging
- Foods
- Polychlorinated biphenyls (PCBs)
21 CFR Part 165
- Beverages
- Bottled water
- Food grades and standards
21 CFR Part 170
- Administrative practice and procedure
- Food additives
- Reporting and recordkeeping requirements
21 CFR Part 184
- Food additives
21 CFR Part 201
- Drugs
- Labeling
- Reporting and recordkeeping requirements
21 CFR Part 312
- Drugs
- Exports
- Imports
- Investigations
- Labeling
- Medical research
- Reporting and recordkeeping requirements
- Safety
21 CFR Part 314
- Administrative practice and procedure
- Confidential business
21 CFR Part 328
- Alcohol and alcoholic beverages
- Labeling
- Over-the-counter drugs
21 CFR Part 330
- Over-the-counter drugs
21 CFR Parts 341, 350, and 355
- Labeling
- Over-the-counter drugs
21 CFR Part 369
- Labeling
- Medical devices
- Over-the-counter drugs
21 CFR Part 500
- Animal drugs
- Animal feeds
- Cancer
- Labeling
- Packaging and containers
- Polychlorinated biphenyls (PCBs)
21 CFR Part 509
- Animal foods
- Packaging and containers
- Polychlorinated biphenyls (PCBs)
21 CFR Parts 514 and 516
- Administrative practice and procedure
- Animal drugs
- Confidential business information; Reporting and recordkeeping requirements
21 CFR Part 570
- Animal feeds
- Animal foods
- Food additives
21 CFR Part 573
- Animal feeds
- Food additives
21 CFR Part 601
- Administrative practice and procedure
- Biologics
- Confidential business information
21 CFR Part 740
- Cosmetics
- Labeling
21 CFR Part 808
- Imports
- Medical devices
- Reporting and recordkeeping requirements
21 CFR Part 812
- Health records
- Medical devices
- Medical research
- Reporting and recordkeeping requirements
21 CFR Part 814
- Administrative practice and procedure
- Confidential business information
- Medical devices
- Medical research
- Reporting and recordkeeping requirements
21 CFR Part 830
- Administrative practice and procedure
- Labeling
- Medical devices
- Reporting and recordkeeping requirements
21 CFR Part 860
- Administrative practice and procedure
- Medical devices
21 CFR Part 861
- Administrative practice and procedure
- Medical devices
- Reporting and recordkeeping requirements
21 CFR Part 895
- Administrative practice and procedure
- Labeling
- Medical devices
21 CFR Part 900
- Electronic products
- Health facilities
- Medical devices
- Radiation protection
- Reporting and recordkeeping requirements
- X-rays
21 CFR Part 1010
- Administrative practice and procedure
- Electronic products
- Exports
- Radiation protection
21 CFR Part 1240
- Communicable diseases
- Public health
- Travel restrictions
- Water supplies
21 CFR Part 1250
- Air carriers
- Foods
- Maritime carriers
- Motor carriers
- Public health
- Railroads
- Water supplies
21 CFR Part 1271
- Biologics
- Communicable diseases
- Drugs
- HIV/AIDS
- Human cells and tissue-based products
- Medical devices
- Reporting and recordkeeping requirements
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR chapter I is amended as follows:
Start PartPART 3—PRODUCT JURISDICTION
End Part Start Amendment Part1. The authority citation for part 3 continues to read as follows:
End Amendment Part[Amended]2. In § 3.5, amend paragraph (a)(1) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 5—ORGANIZATION
End Part Start Amendment Part3. The authority citation for part 5 continues to read as follows:
End Amendment Part[Amended]4. In § 5.1110, amend paragraph (a) by removing “Division of Dockets Management” wherever it appears and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 7—ENFORCEMENT POLICY
End Part Start Amendment Part5. The authority citation for part 7 continues to read as follows:
End Amendment Part[Amended]6. In § 7.42, amend paragraph (b)(3) introductory text by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 10—ADMINISTRATIVE PRACTICES AND PROCEDURE
End Part Start Amendment Part7. The authority citation for part 10 continues to read as follows:
End Amendment Part Start Amendment Part8. In part 10, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start Amendment Part9. In § 10.30, revise paragraph (b)(2) to read as follows:
End Amendment PartCitizen petition.* * * * *(b) * * *
(2) Mail, delivery services, or other non-electronic submissions. A petition (including any attachments), that is not electronically submitted under paragraph (b)(1) of this section, must be submitted in accordance with paragraph (b)(3) of this section and § 10.20 and delivered to this address: Dockets Management Staff, Department of Health and Human Services, Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Submit two copies (original and redacted version) for confidential petitions. Otherwise, only one copy is necessary.
* * * * *PART 12—FORMAL EVIDENTIARY PUBLIC HEARING
End Part Start Amendment Part10. The authority citation for part 12 continues to read as follows:
End Amendment Part Start Amendment Part11. In part 12, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start Printed Page 45065 Start Amendment Part12. In § 12.80, revise paragraph (a) to read as follows:
End Amendment PartFiling and service of submissions.(a) Submissions, including pleadings in a hearing, are to be filed with Dockets Management Staff under § 10.20 of this chapter except that two copies need be submitted (original and redacted version) for confidential petitions. Otherwise, only one copy is necessary. To determine compliance with filing deadlines in a hearing, a submission is considered submitted on the date it is actually received by Dockets Management Staff. When this part allows a response to a submission and prescribes a period of time for the filing of the response, an additional 3 days are allowed for the filing of the response if the submission is served by mail.
* * * * *PART 13—PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY
End Part Start Amendment Part13. The authority citation for part 13 continues to read as follows:
End Amendment Part Start Amendment Part14. In part 13, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
End Part Start Amendment Part15. The authority citation for part 14 continues to read as follows:
End Amendment Part Start Amendment Part16. In part 14, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 15—PUBLIC HEARING BEFORE THE COMMISSIONER
End Part Start Amendment Part17. The authority citation for part 15 continues to read as follows:
End Amendment Part Start Amendment Part18. In part 15, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start Part17—CIVIL MONEY PENALTIES HEARINGS
End Part Start Amendment Part19. The authority citation for part 17 is revised to read as follows:
End Amendment Part Start Amendment Part20. In part 17, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start Amendment Part21. In § 17.31, revise paragraph (a)(1) to read as follows:
End Amendment PartForm, filing, and service of papers.(a) * * *
(1) Documents filed with Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, shall include two copies (original and redacted version) for confidential petitions. Otherwise, only one copy is necessary.
* * * * *PART 20—PUBLIC INFORMATION
End Part Start Amendment Part22. The authority citation for part 20 continues to read as follows:
End Amendment Part[Amended]23. In § 20.120, amend paragraphs (c) introductory text and (c)(3) by removing “Division of Dockets Management's” and adding in its place “Dockets Management Staff's”.
End Amendment Part Start PartPART 25—ENVIRONMENTAL IMPACT CONSIDERATIONS
End Part Start Amendment Part24. The authority citation for part 25 continues to read as follows:
End Amendment Part Start Amendment Part25. In part 25, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 60—PATENT TERM RESTORATION
End Part Start Amendment Part26. The authority citation for part 60 continues to read as follows:
End Amendment Part Start Amendment Part27. In part 60, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 100—GENERAL
End Part Start Amendment Part28. The authority citation for part 100 continues to read as follows:
End Amendment Part[Amended]29. In § 100.1, amend paragraphs (d)(3) and (f)(3) and (4) by removing “Division of Dockets Management” wherever it appears and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 109—UNAVOIDABLE CONTAMINANTS IN FOOD FOR HUMAN CONSUMPTION AND FOOD–PACKAGING MATERIAL
End Part Start Amendment Part30. The authority citation for part 109 continues to read as follows:
End Amendment Part Start Amendment Part31. In part 109, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 165—BEVERAGES
End Part Start Amendment Part32. The authority citation for part 165 continues to read as follows:
End Amendment Part[Amended]33. In § 165.110, amend paragraph (b)(4)(iii)(F) introductory text by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 201—LABELING
End Part Start Amendment Part34. The authority citation for part 201 continues to read as follows:
End Amendment Part[Amended]35. In § 201.63, amend paragraph (d) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 312—INVESTIGATIONAL NEW DRUG APPLICATION
End Part Start Amendment Part36. The authority citation for part 312 continues to read as follows:
End Amendment Part Start Amendment Part37. In part 312, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
End Part Start Amendment Part38. The authority citation for part 314 continues to read as follows:
End Amendment Part Start Amendment Part39. In part 314, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 328—OVER–THE–COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL
End Part Start Amendment Part40. The authority citation for part 328 is revised to read as follows:
End Amendment Part[Amended]41. In § 328.10, amend paragraph (e) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 330—OVER–THE–COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED
End Part Start Amendment Part42. The authority citation for part 330 continues to read as follows:
End Amendment Part Start Amendment Part43. In part 330, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 341—COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER–THE–COUNTER HUMAN USE
End Part Start Amendment Part44. The authority citation for part 341 continues to read as follows:
End Amendment Part[Amended]45. In § 341.85, amend paragraph (c)(4) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 350—ANTIPERSPIRANT DRUG PRODUCTS FOR OVER–THE–COUNTER HUMAN USE
End Part Start Amendment Part46. The authority citation for part 350 continues to read as follows:
End Amendment Part[Amended]47. In § 350.60, remove “Dockets Management Branch” and add in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 355—ANTICARIES DRUG PRODUCTS FOR OVER–THE–COUNTER HUMAN USE
End Part Start Amendment Part48. The authority citation for part 355 continues to read as follows:
End Amendment Part[Amended]49. In § 355.70, amend paragraph (a) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 369—INTERPRETIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER–THE–COUNTER SALE
End Part Start Amendment Part50. The authority citation for part 369 is revised to read as follows:
End Amendment Part[Amended]51. In § 369.21, remove “Division of Dockets Management” and add in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 500—GENERAL
End Part Start Amendment Part52. The authority citation for part 500 continues to read as follows:
End Amendment Part[Amended]53. In § 500.80, amend paragraph (a) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 509—UNAVOIDABLE CONTAMINANTS IN ANIMAL FOOD AND FOOD–PACKAGING MATERIAL
End Part Start Amendment Part54. The authority citation for part 509 continues to read as follows:
End Amendment Part Start Amendment Part55. In part 509, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 514—NEW ANIMAL DRUG APPLICATIONS
End Part Start Amendment Part56. The authority citation for part 514 continues to read as follows:
End Amendment Part[Amended]57. In § 514.200, amend paragraph (c)(1) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 516—NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES
End Part Start Amendment Part58. The authority citation for part 516 continues to read as follows:
End Amendment Part[Amended]59. In § 516.28, amend the introductory text by removing “Division of Dockets Management” and adding “Dockets Management Staff” in its place.
End Amendment Part Start PartPART 570—FOOD ADDITIVES
End Part Start Amendment Part60. The authority citation for part 570 continues to read as follows:
End Amendment Part Start Amendment Part61. In part 570, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part[Amended]62. In § 570.35, amend paragraph (b)(2) by removing “Division of Dockets Management's” and adding in its place “Dockets Management Staff's”.
End Amendment Part Start PartPART 573—FOOD ADDITIVES PERMITTED IN FEED AND DRINKING WATER OF ANIMALS
End Part Start Amendment Part63. The authority citation for part 573 continues to read as follows:
End Amendment Part[Amended]64. In § 573.460, amend paragraphs (a)(1)(i) and (a)(2)(i) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 601—LICENSING
End Part Start Amendment Part65. The authority citation for part 601 continues to read as follows:
End Amendment Part[Amended]66. In § 601.51, amend paragraph (d)(2) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 740—COSMETIC PRODUCT WARNING STATEMENTS
End Part Start Amendment Part67. The authority citation for part 740 is revised to read as follows:
End Amendment Part[Amended]68. In § 740.2, amend paragraph (b) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 808—EXEMPTIONS FROM FEDERAL PREEMPTION OF STATE AND LOCAL MEDICAL DEVICE REQUIREMENTS
End Part Start Amendment Part69. The authority citation for part 808 continues to read as follows:
End Amendment PartSection 808.1 also issued under Sec. 709, Public Law 115–52, 131 Stat. 1065–67.
Start Amendment Part70. In part 808, revise all references to “Division of Dockets Management” to read “Dockets Management Staff”.
End Amendment Part Start PartPART 814—PREMARKET APPROVAL OF MEDICAL DEVICES
End Part Start Amendment Part71. The authority citation for part 814 continues to read as follows:
End Amendment Part[Amended]72. In § 814.9, amend paragraph (d)(2) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 830—UNIQUE DEVICE IDENTIFICATION
End Part Start Amendment Part73. The authority citation for part 830 continues to read as follows:
End Amendment Part[Amended]74. In § 830.10, amend paragraph (a) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 860—MEDICAL DEVICE CLASSIFICATION PROCEDURES
End Part Start Amendment Part75. The authority citation for part 860 continues to read as follows:
End Amendment Part[Amended]76. In § 860.5, amend paragraphs (c)(2) and (d)(2) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 861—PROCEDURES FOR PERFORMANCE STANDARDS DEVELOPMENT
End Part Start Amendment Part77. The authority citation for part 861 continues to read as follows:
End Amendment Part[Amended]78. In § 861.38, amend paragraph (c) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 895—BANNED DEVICES
End Part Start Amendment Part79. The authority citation for part 895 continues to read as follows:
End Amendment Part[Amended]80. In § 895.21, amend paragraph (d)(8) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 900—MAMMOGRAPHY
End Part Start Amendment Part81. The authority citation for part 900 continues to read as follows:
End Amendment Part[Amended]82. In § 900.18, amend paragraphs (d)(2) and (4) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 1010—PERFORMANCE STANDARDS FOR ELECTRONIC PRODUCTS: GENERAL
End Part Start Amendment Part83. The authority citation for part 1010 continues to read as follows:
End Amendment Part[Amended]84. In § 1010.4, amend paragraph (c)(3) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start Amendment Part85. In § 1010.5, revise paragraph (c) introductory text to read as follows:
End Amendment PartExemptions for products intended for United States Government use.* * * * *(c) Application for exemption. If you are submitting an application for exemption, or for amendment or extension thereof, you must submit two copies (original and redacted version) for confidential petitions to Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Otherwise, only one copy is necessary. For an exemption under the criteria prescribed in paragraph (a)(1) of this section, the application shall include the information prescribed in paragraphs (c)(1) through (13) of this section. For an exemption under the criteria prescribed in paragraph (a)(2) of this section, the application shall include the information prescribed in paragraphs (c)(3) through (13) of this section. An application for exemption, or for amendment or extension thereof, and correspondence relating to such application shall be made available for public disclosure in Dockets Management Staff, except for confidential or proprietary information submitted in accordance with part 20 of this chapter. Information classified for reasons of national security shall not be included in the application. Except as indicated in this paragraph (c), the application for exemption shall include the following:
* * * * *PART 1240—CONTROL OF COMMUNICABLE DISEASES
End Part Start Amendment Part86. The authority citation for part 1240 continues to read as follows:
End Amendment Part[Amended]87. In § 1240.62, amend paragraph (d) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 1250—INTERSTATE CONVEYANCE SANITATION
End Part Start Amendment Part88. The authority citation for part 1250 continues to read as follows:
End Amendment Part[Amended]89. In § 1250.51, amend paragraph (f)(4)(ii) by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start PartPART 1271—HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE–BASED PRODUCTS
End Part Start Amendment Part90. The authority citation for part 1271 continues to read as follows:
End Amendment Part[Amended]91. In § 1271.37, amend paragraph (a) introductory text by removing “Division of Dockets Management” and adding in its place “Dockets Management Staff”.
End Amendment Part Start SignatureStart Printed Page 45068End Signature End Supplemental InformationDated: July 6, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–14716 Filed 7–13–23; 8:45 am]
BILLING CODE 4164–01–P
Document Information
- Effective Date:
- 7/14/2023
- Published:
- 07/14/2023
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule; technical amendment.
- Document Number:
- 2023-14716
- Dates:
- This rule is effective July 14, 2023.
- Pages:
- 45063-45068 (6 pages)
- Docket Numbers:
- Docket No. FDA-2023-N-0963
- PDF File:
- 2023-14716.pdf
- CFR: (33)
- 21 CFR 3.5
- 21 CFR 5.1110
- 21 CFR 7.42
- 21 CFR 10.30
- 21 CFR 12.80
- More ...